Key Financial Data Of Reporting Company

Immuno-Biological Laboratories Co., Ltd. - Filing #7737447

Concept 2016-04-01 to
2017-03-31
As at
2017-03-31
As at
2017-03-31
2016-04-01 to
2017-03-31
As at
2016-03-31
As at
2016-03-31
2015-04-01 to
2016-03-31
2015-04-01 to
2016-03-31
2014-04-01 to
2015-03-31
2014-04-01 to
2015-03-31
As at
2015-03-31
As at
2015-03-31
2013-04-01 to
2014-03-31
As at
2014-03-31
2013-04-01 to
2014-03-31
As at
2014-03-31
2012-04-01 to
2013-03-31
As at
2013-03-31
As at
2013-03-31
2012-04-01 to
2013-03-31
Key financial data of reporting company
Business results of reporting company
Net sales
653,477,000 JPY
741,525,000 JPY
595,057,000 JPY
717,661,000 JPY
595,437,000 JPY
729,030,000 JPY
547,149,000 JPY
670,428,000 JPY
JPY
800,081,000 JPY
Ordinary profit (loss)
-1,131,250,000 JPY
-1,170,355,000 JPY
-29,681,000 JPY
-81,797,000 JPY
-41,247,000 JPY
-139,084,000 JPY
-112,198,000 JPY
-99,758,000 JPY
JPY
80,448,000 JPY
Profit (loss)
-2,109,157,000 JPY
-55,321,000 JPY
-110,317,000 JPY
-126,528,000 JPY
153,077,000 JPY
Equity in earnings (losses) of affiliates if equity method is applied
JPY
JPY
JPY
JPY
JPY
Share capital
2,271,815,000 JPY
1,946,344,000 JPY
1,846,099,000 JPY
1,846,099,000 JPY
1,571,810,000 JPY
Total number of issued shares
7,419,590 xbrli:shares
6,752,590 xbrli:shares
6,547,590 xbrli:shares
6,547,590 xbrli:shares
616,400 xbrli:shares
Net assets
1,341,441,000 JPY
1,342,190,000 JPY
2,786,374,000 JPY
2,801,813,000 JPY
2,658,428,000 JPY
2,619,566,000 JPY
2,794,736,000 JPY
2,763,270,000 JPY
2,247,202,000 JPY
JPY
Total assets
3,425,900,000 JPY
3,392,596,000 JPY
3,356,321,000 JPY
3,359,296,000 JPY
3,163,071,000 JPY
3,138,040,000 JPY
3,147,094,000 JPY
3,070,932,000 JPY
2,614,078,000 JPY
JPY
Net assets per share
180.23
180.33
411.84
414.13
404.93
398.99
422.69
420.88
364.57
Dividend paid per share
5.00
Interim dividend paid per share
Basic earnings (loss) per share
-289.54
-287.52
-8.42
-4.86
-16.84
-24.20
-19.85
-17.99
24.83
Diluted earnings per share
Equity-to-asset ratio
0.390 xbrli:pure
0.394 xbrli:pure
0.828 xbrli:pure
0.832 xbrli:pure
0.838 xbrli:pure
0.832 xbrli:pure
0.879 xbrli:pure
0.897 xbrli:pure
0.860 xbrli:pure
xbrli:pure
Rate of return on equity
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
0.071 xbrli:pure
Price-earnings ratio
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
116.0 xbrli:pure
Payout ratio
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
0.201 xbrli:pure
Net cash provided by (used in) operating activities
JPY
-55,886,000 JPY
JPY
-16,984,000 JPY
JPY
-108,999,000 JPY
JPY
12,161,000 JPY
JPY
228,703,000 JPY
Net cash provided by (used in) investing activities
JPY
-458,490,000 JPY
JPY
-607,709,000 JPY
JPY
21,835,000 JPY
JPY
-136,903,000 JPY
JPY
-34,362,000 JPY
Net cash provided by (used in) financing activities
JPY
2,145,528,000 JPY
JPY
286,671,000 JPY
JPY
163,736,000 JPY
JPY
464,540,000 JPY
JPY
185,664,000 JPY
Cash and cash equivalents
2,522,102,000 JPY
JPY
891,915,000 JPY
JPY
JPY
1,232,210,000 JPY
1,135,786,000 JPY
JPY
793,694,000 JPY
JPY
Number of employees
56 xbrli:pure
47 xbrli:pure
54 xbrli:pure
45 xbrli:pure
45 xbrli:pure
55 xbrli:pure
52 xbrli:pure
41 xbrli:pure
44 xbrli:pure
xbrli:pure
Average number of temporary employees
11 xbrli:pure
9 xbrli:pure
12 xbrli:pure
10 xbrli:pure
11 xbrli:pure
13 xbrli:pure
11 xbrli:pure
9 xbrli:pure
10 xbrli:pure
xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.